Shanghai MicroPort Endovascular MedTech (688016) Stock Overview

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. Its products include thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems, aortic dissection, percutaneous transluminal angioplasty, and balloon catheters, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was founded in 2012 and is based in Shanghai, the People's Republic of China.